<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046639"><TermName>mercaptopurine</TermName><TermPronunciation>(mer-KAP-toh-PYOOR-een)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat acute lymphoblastic leukemia. It may also be used to treat certain other conditions, such as Crohn disease and ulcerative colitis. Mercaptopurine stops cells from dividing and may kill cancer cells. It is a type of antimetabolite. Also called Purinethol and Purixan.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731692" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mercaptopurine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731693" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mercaptopurina&quot;" language="es" id="_4"/><SpanishTermName>mercaptopurina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia linfoblástica aguda. Se puede usar para tratar otras afecciones, como la enfermedad de Crohn y la colitis ulcerativa.  impide que las células se multipliquen y puede destruir células cancerosas. Es un tipo de antimetabolito. También se llama Purinetol y Purixan.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2013-07-10</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000749756">Mercaptopurine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
